Image Credits - Rotten TomatoesRenowned director Bong Joon Ho’s latest venture into science fiction, “Mickey 17,” has sparked a spectrum of reactions since its release. The film features Robert Pattinson as an “expendable” employee on a colonization mission to the ice planet Niflheim, exploring themes of identity and human expendability.
The film has elicited mixed reviews from critics. Notably, Spanish film critic Carlos Boyero expressed his discontent, stating he couldn’t find any appeal in the movie and even left the theatre before it concluded. Boyero criticized the film’s plot and its comedic tone, mentioning his general disinterest in science fiction as a genre.
Box Office Performance
Financially, “Mickey 17” has faced challenges. In its second weekend, the film experienced a significant 60% drop in domestic earnings, bringing its total to $33.2 million against a production budget of $118 million. Internationally, it fared better, adding $23 million for a global total of $90.4 million. However, it was surpassed at the domestic box office by the action-comedy “Novocaine,” which debuted with $8.7 million, highlighting a sluggish period for theatres.
Release Date Adjustments
Prior to its release, “Mickey 17” underwent several schedule changes. Initially set for March 29, 2024, it was postponed to January 31, 2025, and later to April 18, 2025, before finally premiering on March 7, 2025. These shifts were part of Warner Bros.’ strategy to optimize the film’s performance and align with IMAX availability.
Despite the mixed critical reception and underwhelming domestic box office performance, “Mickey 17” continues to engage audiences with its complex narrative and Bong Joon Ho’s distinctive directorial approach. As the film remains in theatres, its long-term impact and reception are yet to be fully realized.
